DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study

This publication has 21 references indexed in Scilit:

• DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
  Genetics in Medicine, 2011
• Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting
  American Journal of Obstetrics and Gynecology, 2011
• Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study
  BMJ, 2011
• The maternal age‐specific live birth prevalence of trisomies 13 and 18 compared to trisomy 21 (Down syndrome)
  Prenatal Diagnosis, 2009
• The risk of fetal loss following a prenatal diagnosis of trisomy 13 or trisomy 18
  American Journal of Medical Genetics Part A, 2008
• Population-Based Analyses of Mortality in Trisomy 13 and Trisomy 18
  Pediatrics, 2003
• Maternal serum–integrated screening for trisomy 18 using both first‐ and second‐trimester markers
  Prenatal Diagnosis, 2003
• Patterns of first‐year survival among infants with selected congenital anomalies in Texas, 1995–1997
  Teratology, 2001
• Screening for trisomy 18 by fetal nuchal translucency and maternal serum free β -hCG and PAPP-A at 10-14 weeks of gestation
  Prenatal Diagnosis, 1999
• Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin
  Prenatal Diagnosis, 1995